These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 445955)

  • 1. Absorption and excretion of tolmetin in arthritic patients.
    Grindel JM; Migdalof BH; Plostnieks J
    Clin Pharmacol Ther; 1979 Jul; 26(1):122-8. PubMed ID: 445955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of tolmetin kinetics in rheumatoid arthritis and matched healthy controls.
    Furst DE; Dromgoole SH; Fow S; Landaw EM
    J Clin Pharmacol; 1983; 23(11-12):557-62. PubMed ID: 6662979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolmetin kinetics and synovial fluid prostaglandin E levels in rheumatoid arthritis.
    Dromgoole SH; Furst DE; Desiraju RK; Nayak RK; Kirschenbaum MA; Paulus HE
    Clin Pharmacol Ther; 1982 Sep; 32(3):371-7. PubMed ID: 7105628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zomepirac kinetics in healthy males.
    Nayak RK; Ng KT; Gottlieb S; Plostnieks J
    Clin Pharmacol Ther; 1980 Mar; 27(3):395-401. PubMed ID: 7357796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of tolmetin and its metabolite in biological fluids by high-performance liquid chromatography.
    Desiraju RK; Sedberry DC; Ng KT
    J Chromatogr; 1982 Oct; 232(1):119-28. PubMed ID: 7142320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on disposition and metabolism of tolmetin, a new anti-inflammatory agent, in rats and mice. I. Absorption, distribution, and excrection of [14C]tolmetin radioactivity.
    Hashimoto M; Miyazaki H; Fujii T; Nambu K; Tanaka K
    Drug Metab Dispos; 1979; 7(1):14-9. PubMed ID: 35320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption and excretion of tolemetin in man.
    Cressman WA; Wortham GF; Plostnieks J
    Clin Pharmacol Ther; 1976 Feb; 19(2):224-33. PubMed ID: 1261159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of zomepirac sodium in man.
    O'Neill PJ; Yorgey KA; Renzi NL; Williams RL; Benet LZ
    J Clin Pharmacol; 1982 Oct; 22(10):470-6. PubMed ID: 7174855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear and nonlinear assessment of tolmetin pharmacokinetics.
    Ayres JW; Weidler DJ; Sakmar E; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):583-93. PubMed ID: 897347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolism of zomepirac sodium. I. Disposition in laboratory animals and man.
    Grindel JM; O'Neill PJ; Yorgey KA; Schwartz MH; McKown LA; Migdalof BH; Wu WN
    Drug Metab Dispos; 1980; 8(5):343-8. PubMed ID: 6107233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on disposition and metabolism of tolmetin, a new anti-inflammatory agent, in rats and mice. II. Urinary metabolites.
    Hashimoto M; Miyazaki H; Nambu K; Fujii T; Arakawa S; Yoshida K; Utsui Y
    Drug Metab Dispos; 1979; 7(1):20-3. PubMed ID: 35321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of probenecid on the formation and elimination of acyl glucuronides: studies with zomepirac.
    Smith PC; Langendijk PN; Bosso JA; Benet LZ
    Clin Pharmacol Ther; 1985 Aug; 38(2):121-7. PubMed ID: 3874742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition and irreversible plasma protein binding of tolmetin in humans.
    Hyneck ML; Smith PC; Munafo A; McDonagh AF; Benet LZ
    Clin Pharmacol Ther; 1988 Jul; 44(1):107-14. PubMed ID: 3390998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic studies of tolmetin in man.
    Selley ML; Glass J; Triggs EJ; Thomas J
    Clin Pharmacol Ther; 1975 May; 17(5):599-605. PubMed ID: 1126116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The time course of tolmetin and its metabolites in the plasma of individual rats and mice.
    Migdalof BH; Yorgey KA; Popkave CG
    Drug Metab Dispos; 1976; 4(5):468-73. PubMed ID: 10146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the pharmacokinetics and metabolism of zomepirac in man and animals.
    Muschek LD; Grindel JM
    J Clin Pharmacol; 1980 Apr; 20(4):223-9. PubMed ID: 6769977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein binding of tolmetin.
    Selley ML; Madsen BW; Thomas J
    Clin Pharmacol Ther; 1978 Dec; 24(6):694-705. PubMed ID: 710027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and metabolism of tolmetin in normal and adjuvant arthritic Lewis rats.
    Grindel JM; Migdalof BH; Yorgey KA; Pritchard JF
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):299-306. PubMed ID: 6984679
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal handling of zomepirac sodium (McN-2783-21-98) in the rat.
    O'Neill PJ; Yorgey KA; Migdalof BH; Gussin RZ
    J Pharmacol Exp Ther; 1979 Jun; 209(3):366-70. PubMed ID: 35605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of tolmetin: comparisons in rheumatoid arthritis patients and normal volunteers.
    Furst DE; Dromgoole SH; Desiraju RK; Paulus HE
    J Clin Pharmacol; 1983 Jul; 23(7):329-35. PubMed ID: 6886031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.